For these reasons, I have opened a position
The surprisingly strong preliminary Q2 figures could indicate that the annual forecast is too conservative!
The new production facility in Serbia could help better meet the high demand for pharmaceutical vials in the European market!
Reading Time: 1 minute
Market uncertainty has significantly increased due to US tariff policies and a potentially escalating situation between China and the USA. In such times, investors increasingly seek a safe haven like gold. I believe this could also bring the fundamentals and perspectives of more defensive stocks back into focus. In this context, I was positively surprised by SCHOTT Pharma (i.) with the preliminary figures for the second quarter presented after trading hours on April 10. Accordingly, revenue was about 4.1% and EBITDA even about 16.1% above the forecast!...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
